D-0982-2017 Class III Terminated
FDA drug recall D-0982-2017 was initiated by Shionogi Inc. on May 24, 2017 and is designated Class III. Reason for recall: Failed Dissolution Specifications: Low dissolution results were obtained during stability testing The recall status is terminated (terminated Feb 28, 2018). Affected quantity: 455 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 26, 2017
- Initiation Date
- May 24, 2017
- Termination Date
- Feb 28, 2018
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 455 bottles
Product description
PONSTEL (Mefanamic Acid) USP, 250 mg capsules, 30-count bottles, Rx Only, Manufactured for: Shionogi Inc. Florham Park, NJ 07932 Manufactured by: Halo Pharmaceutical Inc. Whippany, NJ 07981
Reason for recall
Failed Dissolution Specifications: Low dissolution results were obtained during stability testing
Distribution pattern
Nationwide
Code information
Lot #: 5H66200103, Exp. June 2018
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0982-2017
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026